Acute Kidney Injury

Nephrology·MeSH: Acute Kidney Injury

11 drugs in development·7 companies·13 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
quelimmune	SeaStar Medical Holding Corporation (ICU)

Phase 2(5)

Phase 1(2)

Drug	Company
Allogeneic HB-adMSCs	Accustem Sciences Inc. (ACUT)
uni-494	Unicycive Therapeutics, Inc. (UNCY)

Phase 4(3)

Drug	Company
Cefepime	ENANTA PHARMACEUTICALS INC (ENTA)
Piperacillin-tazobactam	ENANTA PHARMACEUTICALS INC (ENTA)
Vancomycin	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 11 drugs in development for Acute Kidney Injury across 7 companies.

There are 13 clinical trials targeting Acute Kidney Injury tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.